IMMUNE CHECKPOINT INHIBITORS
Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment
Although myocarditis is a rare immune-related adverse event (iRAE) associated with immune checkpoint inhibitors, the iRAE has a reportedly high mortality rate. Learn more about the mechanisms and clinical presentation of myocardial toxicity related to ICI therapy, appropriate diagnostic testing, and treatment strategies.
Journal of the American Heart AssociationMeet the Faculty
Videos
-
Immune Checkpoint Inhibitors Managing Cardiotoxicity Associated With Immune Checkpoint Inhibitor Therapy
-
Immune Checkpoint Inhibitors Immune Checkpoint Inhibitors and Cardiotoxicity: Incidence and Patient Risk Factors
-
Immune Checkpoint Inhibitors Immune Checkpoint Inhibitors and Cardiotoxicity: The Pharmacist Perspective
